Biomarkers in early-stage colorectal cancer: ready for prime time?
BACKGROUND/AIMS: During the last two decades, hundreds of reports have detailed putative prognostic and predictive biomarkers for colorectal cancer (CRC). However, the majority of these studies have been small and retrospective, reporting results that are highly likely to represent false positives....
Auteurs principaux: | Church, D, Midgley, R, Kerr, D |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
2012
|
Documents similaires
-
Adjuvant chemotherapy for stage II colorectal cancer: the time is right!
par: Midgley, R, et autres
Publié: (2005) -
The emergence of 'omics for the management of colorectal cancer.
par: Midgley, R, et autres
Publié: (2011) -
Adjuvant chemotherapy for stage II colorectal cancer: who should receive therapy and with what?
par: Midgley, R, et autres
Publié: (2005) -
Circulating tumor DNA in early-stage colon cancer: ready for prime time or needing refinement?
par: Joao Paulo Solar Vasconcelos, et autres
Publié: (2022-12-01) -
Immunotherapy for colorectal cancer.
par: Midgley, R, et autres
Publié: (2003)